Reactions Weekly

, Volume 1126, Issue 1, pp 2–2 | Cite as

Acute rejection with sirolimus + CellCept + corticosteroids

News item

Keywords

Corticosteroid Acute Rejection Sirolimus Mycophenolate Mofetil Calcineurin Inhibitor 

REFERENCE

  1. 1.
    Hoffman-La Roche Limited.Higher than expected incidence of acute rejection in cardiac transplant patients switched from calcineurin inhibitors (CNI) to sirolimus in combination with CellCept (Rm) (mycophenolate mofetil) at 12 weeks post heart transplantation. Company Communication: [4 pages], 13 Oct 2006. Available from: URL: http://www.hc-sc.gc.ca
  2. 2.
    Hoffmann-La Roche Limited.Higher than expected rate of rejection in heart transplant patients treated with an investigational immunosuppressant combination of sirolimus, CellCept (Rm) (mycophenolate mofetil), and corticosteroids. Company Communication: [2 pages], 13 Oct 2006. Available from: URL: http://www.hc-sc.gc.ca

Copyright information

© Adis International limited or Adis Data Information BV 2006

Personalised recommendations